Torchmark Corporation ($GL) Stock Forecast: Down 4.0% Today

What is Torchmark Corporation?

Globe Life Inc. (NYSE: GL) operates as a holding company specializing in life and supplemental health insurance for middle-income households in the US. The stock recently reached an all-time high before experiencing a bearish movement.

Why is Torchmark Corporation going down?

GL stock is down 4.0% on May 19, 2026 19:55

• An insider's sale of 20,000 shares subsequent to a stock option exercise could have indicated profit-taking, triggering concerns among investors and contributing to the bearish movement.
• Even though the stock had reached record levels and received favorable analyst projections, persistent governance issues and controversies surrounding the company may have dampened investor confidence, leading to the downward trend.
• Previous instances of a short-seller report and a rating downgrade have further added to uncertainties and potential reputation risks for the company, potentially influencing the current market conditions.
• The strong performance in earnings and positive analyst sentiment towards MetLife Inc., a competitor in the insurance sector, might have diverted investor focus from Globe Life Inc., thereby impacting its stock performance adversely.

GL Price Chart

GL Technical Analysis

GL News

Globe Life (NYSE: GL) proposed Rule 144 sale of 20,000 shares

Globe Life Inc. (NYSE: GL) has filed a Rule 144 notice for the proposed sale of 20,000 shares of common stock, stemming from a stock option exercise, with a proposed sale date of May 19, 2026. The filing also indicates a prior sale of 12,854 shares on May 5, 2026, generating $1,974,421.95. This notice serves as a regulatory notification of intent rather than a confirmation of the actual sale.

https://www.stocktitan.net/sec-filings/GL/144-globe-life-inc-sec-filing-74538dba0c0a.html

Globe Life (NYSE: GL) insider files to sell 35,000 shares after option exercise

Thomas Kalmbach, an insider at Globe Life Inc. (NYSE: GL), has filed a Form 144 to sell 35,000 shares of common stock following a stock option exercise on May 19, 2026. The filing also reveals previous sales in May 2026 totaling 27,427 shares, generating proceeds of over $4.1 million. The Securities Compliance Analyst described the filing as a routine notice of proposed resale by an affiliate.

https://www.stocktitan.net/sec-filings/GL/144-globe-life-inc-sec-filing-2df2b6720a81.html

Globe Life stock hits all-time high at 156.97 USD By Investing.com

Globe Life Inc. stock has reached a new all-time high of $156.97, reflecting a 27.95% appreciation over the past year. Despite a slight miss in Q1 2026 EPS, analysts maintain a positive outlook, with several firms raising their price targets due to the company's strong cash flow generation and consistent dividend increases. The stock trades at an attractive PEG ratio, suggesting potential undervaluation.

https://au.investing.com/news/company-news/globe-life-stock-hits-alltime-high-at-15697-usd-93CH-4442270

Globe Life Inc. stock (US37959E1029): Investor focus after short-seller report, governance questions

Globe Life Inc. has been under intense scrutiny in 2024 following a short-seller report, subsequent lawsuits, and a rating downgrade, which has raised questions about its governance and business model. The company operates as a holding company for various insurance subsidiaries, focusing on life and supplemental health coverage for middle-income households in the US, with premium income from these policies and investment income driving its revenue. Despite its historically stable business model and capital return strategies, the ongoing controversies pose significant uncertainty and reputational risk, making it a critical case study for US investors observing corporate governance and market sentiment in the insurance sector.

https://www.ad-hoc-news.de/boerse/news/ueberblick/globe-life-inc-stock-us37959e1029-investor-focus-after-short-seller/69363012

MetLife stock (US59156R1086): earnings beat and analyst optimism keep the spotlight on the insurer

MetLife Inc. started 2026 with better-than-expected quarterly earnings, reporting an EPS of $2.42 against an analyst estimate of $2.27, demonstrating solid underwriting and investment income. Analyst sentiment is largely positive, with a "Moderate Buy" consensus and an average twelve-month price target of $95.15, suggesting a potential upside of approximately 19%. The article highlights MetLife's diversified business model, global reach, and the importance of US labor market trends and interest rates to its performance.

https://www.ad-hoc-news.de/boerse/news/ueberblick/metlife-stock-us59156r1086-earnings-beat-and-analyst-optimism-keep-the/69361803

Trending Today

Silver ($XAG) Commodity Forecast: Down 5.1% Today

SL Green Realty Corp ($SLG) Stock Forecast: Down 5.3% Today

Torchmark Corporation ($GL) Stock Forecast: Down 4.0% Today

Xerox Corporation ($XRX) Stock Forecast: Down 5.2% Today

Akamai Technologies Inc. ($AKAM) Stock Forecast: Down 5.6% Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Down 5.5% Today

Moderna Inc. ($MRNA) Stock Forecast: Down 5.1% Today

Edison International ($EIX) Stock Forecast: Up 7.1% Today

Pacific Gas & Electric Co. ($PCG) Stock Forecast: Up 5.5% Today

Zebra Technologies Corporation ($ZBRA) Stock Forecast: Down 5.5% Today

Torchmark Corporation Price History

23.03.2026 - GL Stock was up 2.1%

• Despite falling short of Q1 earnings expectations, Globe Life recorded double-digit profit growth and heightened its full-year 2026 earnings outlook, demonstrating confidence in its future prospects.
• Positive momentum was driven by strategic share buybacks and robust performances in life and health insurance units.
• Market sentiment remains buoyant despite GL being evaluated as 3.1% overvalued by GuruFocus and insider selling activity, given the increased earnings guidance and strong operational results.
• The rise in quarterly dividends and emphasis on improving shareholder value through share repurchases further bolstered investor confidence in Globe Life.

23.03.2026 - GL Stock was up 5.1%

• Despite not meeting EPS expectations, Globe Life's stock rallied due to a 12% rise in net operating income per share compared to last year, coupled with investor confidence in strategic measures such as investments in AI for cost efficiencies.
• Investor trust was bolstered by the company's uninterrupted dividend payments for over 56 years, ongoing share repurchase programs, and clear responses regarding lapse rates and AI advantages.
• By revising the anticipated full-year 2026 earnings to $15.40-$15.90 per diluted share, Globe Life indicated strong belief in its future performance, which resonated positively with investors.
• The market's focus appears to be shifting towards the company's optimistic trajectory, strategic endeavors, and long-term prospects, overshadowing the Q1 earnings miss and propelling the stock upwards.

05.01.2026 - GL Stock was up 1.9%

• The bullish movement in Globe Life Inc. (GL) stock today can be explained by several key factors:
• Strong growth in life and health insurance net sales despite missing earnings estimates, reflecting solid sales momentum.
• Completion of a significant share repurchase program, signaling confidence in future performance and potentially attracting investor interest.
• Market response to the company's undervaluation, with a notable stock price surge subsequent to a fair value alert in April 2024 by InvestingPro.
• Reassurance to investors regarding the company's financial health due to profitability metrics like a return on equity of 21.81% and a net margin of 19.36%, mitigating concerns from the earnings shortfall.

19.04.2026 - GL Stock was down 4.0%

• An insider's sale of 20,000 shares subsequent to a stock option exercise could have indicated profit-taking, triggering concerns among investors and contributing to the bearish movement.
• Even though the stock had reached record levels and received favorable analyst projections, persistent governance issues and controversies surrounding the company may have dampened investor confidence, leading to the downward trend.
• Previous instances of a short-seller report and a rating downgrade have further added to uncertainties and potential reputation risks for the company, potentially influencing the current market conditions.
• The strong performance in earnings and positive analyst sentiment towards MetLife Inc., a competitor in the insurance sector, might have diverted investor focus from Globe Life Inc., thereby impacting its stock performance adversely.